Brian Schulte

Brian Schulte practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Brian Schulte's NPI, 1639563679, was assigned on March 27, 2015. Brian Schulte graduated from Medical College Of Wisconsin in 2015. Brian Schulte holds California license 171740.

Brian Schulte's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Brian Schulte's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Brian Schulte is also affiliated with MarinHealth Medical Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Brian Schulte to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Brian Schulte practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Brian Schulte's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Brian Schulte is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Brian Schulte's licenses on file in 3 states: California, Illinois and Colorado.

Dmand AI lists breast cancer, chronic embolism thrombosis, colorectal cancer, deep vein thrombosis (DVT), lung cancer and prostate cancer among the conditions Brian Schulte treats.

CMS data shows 520 Medicare services from Brian Schulte across 6 procedure codes in 2024, for 121 Medicare patients. Medicare paid $35,109 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 121 Medicare patients who saw Brian Schulte in 2024. The largest group is 65 to 74, with 62 patients. 69% of them have high cholesterol, and 58% have high blood pressure. 37% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Brian Schulte's median patient age at 64, with 48% women.

In 2024, Brian Schulte wrote 191 Medicare Part D claims for 37 patients. 63% of them were for generic drugs. CMS names the drug for 40 of them, across 2 drugs with 11 or more claims each, at $12,199 in total drug cost. In 2022, CMS named 37 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Brian Schulte for performance year 2024, reported as part of a group. Brian Schulte accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Brian Schulte as offering telehealth.

Dmand AI links 14 papers to Brian Schulte, published from 2014 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Cell Line, Tumor, Cytokines and Macrophages. Brian Schulte has published most often in BMJ Case Rep. Brian Schulte's most frequent co-authors are Mark Agulnik, MD, Borislav A. Alexiev, MD and Lee Cranmer, MD, PhD.

CMS Open Payments shows 13 general payments to Brian Schulte from 7 drug and device companies from 2018 to 2025. Honoraria make up the largest share, 77% of the total. Aadi Bioscience, Inc. paid the most, $1,762.

Brian Schulte graduated from Medical College Of Wisconsin in 2015. Brian Schulte is a member of ASCO.

Brian Schulte is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.